Bevacizumab attenuates hepatic fibrosis in rats by inhibiting activation of hepatic stellate cells.

MLA

Yangqing Huang, et al. “Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells.” PLoS ONE, vol. 8, no. 8, Jan. 2013, p. e73492. EBSCOhost, https://doi.org/10.1371/journal.pone.0073492.

APA

Yangqing Huang, Helin Feng, Tong Kan, Bin Huang, Minfeng Zhang, Yesheng Li, Changying Shi, Mengchao Wu, Yunquan Luo, Jiamei Yang, & Feng Xu. (2013). Bevacizumab attenuates hepatic fibrosis in rats by inhibiting activation of hepatic stellate cells. PLoS ONE, 8(8), e73492. https://doi.org/10.1371/journal.pone.0073492

Chicago

Yangqing Huang, Helin Feng, Tong Kan, Bin Huang, Minfeng Zhang, Yesheng Li, Changying Shi, et al. 2013. “Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells.” PLoS ONE 8 (8): e73492. doi:10.1371/journal.pone.0073492.